Literature DB >> 27057818

Multiplexing and Beyond in Biobehavioral Research.

Paul J Mills1, Christine T Peterson.   

Abstract

In contrast to traditional singleplex assays that provide values for only a single analyte in a single biological sample, multiplex assays are a time- and resource-efficient high-throughput approach that provides the opportunity to determine numerous analytes within a single- and small-sample volume. In this editorial on an article by Dorn et al. in this issue of Psychosomatic Medicine, we provide a brief description of the advantages and challenges related to multiplex assays. Although the use of multiplexing as a tool has been relatively limited in biobehavioral research, more recent studies are taking advantage of this technology to obtain deeper insight into regulatory patterns in health and disease states. Multiplex approaches range from several targets to global target profiling that importantly enable unbiased biomarker and pathway discovery.

Entities:  

Mesh:

Year:  2016        PMID: 27057818      PMCID: PMC6594161          DOI: 10.1097/PSY.0000000000000329

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  20 in total

1.  Challenges in interpreting cytokine biomarkers in biobehavioral research: a breast cancer exemplar.

Authors:  Debra Lyon; Jeanne Walter; Cindy L Munro; Christine M Schubert; Nancy L McCain
Journal:  Biol Res Nurs       Date:  2011-01       Impact factor: 2.522

Review 2.  Biomarkers: potential uses and limitations.

Authors:  Richard Mayeux
Journal:  NeuroRx       Date:  2004-04

Review 3.  Multiplexed protein measurement: technologies and applications of protein and antibody arrays.

Authors:  Stephen F Kingsmore
Journal:  Nat Rev Drug Discov       Date:  2006-04       Impact factor: 84.694

4.  Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA.

Authors:  Mohamed F Elshal; J Philip McCoy
Journal:  Methods       Date:  2006-04       Impact factor: 3.608

5.  Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: relationship with depression and fatigue.

Authors:  J C Felger; S W Cole; T W W Pace; F Hu; B J Woolwine; G H Doho; C L Raison; A H Miller
Journal:  Psychol Med       Date:  2011-12-09       Impact factor: 7.723

6.  Multisite comparison of high-sensitivity multiplex cytokine assays.

Authors:  Elizabeth Crabb Breen; Sandra M Reynolds; Christopher Cox; Lisa P Jacobson; Larry Magpantay; Candice B Mulder; Oliver Dibben; Joseph B Margolick; Jay H Bream; Elise Sambrano; Otoniel Martínez-Maza; Elizabeth Sinclair; Persephone Borrow; Alan L Landay; Charles R Rinaldo; Philip J Norris
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

Review 7.  Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems.

Authors:  Mitja Lainscak; Stefan D Anker
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

8.  An assessment of histone-modification antibody quality.

Authors:  Thea A Egelhofer; Aki Minoda; Sarit Klugman; Kyungjoon Lee; Paulina Kolasinska-Zwierz; Artyom A Alekseyenko; Ming-Sin Cheung; Daniel S Day; Sarah Gadel; Andrey A Gorchakov; Tingting Gu; Peter V Kharchenko; Samantha Kuan; Isabel Latorre; Daniela Linder-Basso; Ying Luu; Queminh Ngo; Marc Perry; Andreas Rechtsteiner; Nicole C Riddle; Yuri B Schwartz; Gregory A Shanower; Anne Vielle; Julie Ahringer; Sarah C R Elgin; Mitzi I Kuroda; Vincenzo Pirrotta; Bing Ren; Susan Strome; Peter J Park; Gary H Karpen; R David Hawkins; Jason D Lieb
Journal:  Nat Struct Mol Biol       Date:  2010-12-05       Impact factor: 15.369

9.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

10.  Plasma biomarkers of depressive symptoms in older adults.

Authors:  S E Arnold; S X Xie; Y-Y Leung; L-S Wang; M A Kling; X Han; E J Kim; D A Wolk; D A Bennett; A Chen-Plotkin; M Grossman; W Hu; V M-Y Lee; R Scott Mackin; J Q Trojanowski; R S Wilson; L M Shaw
Journal:  Transl Psychiatry       Date:  2012-01-03       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.